Relapses
A total of 25 patients relapsed, constituting 17.4%. The relapse rate
is higher among stage III (17) patients and stage IV (6) patients. One
patient had progressive disease while on chemotherapy, and three
patients had partial/no response. Five patients were salvaged with
second-line treatment and are alive and well when last seen. Five died,
and 15 patients were lost for follow up. Most relapses occurred in the
patients who completed treatment (18). The most common site of relapse
is primary site 17(68%), lung and local 7(28%).).